HALOBETASOL PROPIONATE AND TAZAROTENE

HALOBETASOL PROPIONATE AND TAZAROTENE was reported 198 times

These side effects are most commonly reported by patients taking HALOBETASOL PROPIONATE AND TAZAROTENE:

# Side effect Count
0 PSORIASIS 50
1 DRUG INEFFECTIVE 19
2 PRURITUS 16
3 PRODUCT DOSE OMISSION ISSUE 15
4 HEADACHE 14
5 NAUSEA 12
6 DIARRHOEA 11
7 APPLICATION SITE PAIN 10
8 RASH 10
9 SKIN BURNING SENSATION 10
10 OFF LABEL USE 9
11 SKIN EXFOLIATION 9
12 APPLICATION SITE ERYTHEMA 8
13 APPLICATION SITE IRRITATION 8
14 ERYTHEMA 8
15 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 8
16 PAIN 8
17 PRODUCT USE IN UNAPPROVED INDICATION 8
18 COVID-19 7
19 FATIGUE 7
20 DERMATITIS ATOPIC 6
21 DRY SKIN 6
22 PERIPHERAL SWELLING 6
23 SKIN IRRITATION 6
24 THERAPY NON-RESPONDER 6
25 VOMITING 6
26 ARTHRALGIA 5
27 BURNING SENSATION 5
28 PNEUMONIA 5
29 PSORIATIC ARTHROPATHY 5
30 TREATMENT FAILURE 5
31 ABDOMINAL PAIN UPPER 4
32 APPLICATION SITE PRURITUS 4
33 DIZZINESS 4
34 JOINT SWELLING 4
35 MATERNAL EXPOSURE DURING PREGNANCY 4
36 SKIN ATROPHY 4
37 SKIN DISCOLOURATION 4
38 SKIN EROSION 4
39 SLEEP DISORDER 4
40 SQUAMOUS CELL CARCINOMA 4
41 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4
42 ABORTION SPONTANEOUS 3
43 ACCIDENTAL EXPOSURE TO PRODUCT 3
44 APPLICATION SITE RASH 3
45 DECREASED APPETITE 3
46 DEVICE DISLOCATION 3
47 DRUG HYPERSENSITIVITY 3
48 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3
49 ECZEMA 3
50 FEELING ABNORMAL 3
51 GAIT DISTURBANCE 3
52 ILLNESS 3
53 INTENTIONAL PRODUCT USE ISSUE 3
54 KNEE ARTHROPLASTY 3
55 OSTEOMYELITIS 3
56 PAIN OF SKIN 3
57 PUSTULE 3
58 RASH ERYTHEMATOUS 3
59 SKIN INDURATION 3
60 SWELLING 3
61 SWELLING FACE 3
62 THERAPEUTIC RESPONSE DECREASED 3
63 ABDOMINAL DISCOMFORT 2
64 ABDOMINAL PAIN 2
65 ANKLE FRACTURE 2
66 APPLICATION SITE EXFOLIATION 2
67 BASAL CELL CARCINOMA 2
68 BLOOD PRESSURE INCREASED 2
69 BOWENOID PAPULOSIS 2
70 BOWEN^S DISEASE 2
71 CELLULITIS 2
72 CHILLS 2
73 CONDITION AGGRAVATED 2
74 CONTRAINDICATED PRODUCT ADMINISTERED 2
75 COUGH 2
76 DENTAL IMPLANTATION 2
77 DEPRESSION 2
78 DERMATITIS CONTACT 2
79 DISEASE RECURRENCE 2
80 EXFOLIATIVE RASH 2
81 FACIAL OPERATION 2
82 GENITAL ERYTHEMA 2
83 HAIR GROWTH ABNORMAL 2
84 HYPERSENSITIVITY 2
85 INFLUENZA 2
86 INJECTION SITE HAEMORRHAGE 2
87 INJECTION SITE PAIN 2
88 INJECTION SITE REACTION 2
89 KERATOACANTHOMA 2
90 KIDNEY INFECTION 2
91 LICHENOID KERATOSIS 2
92 LIMB OPERATION 2
93 LOCALISED INFECTION 2
94 MAJOR DEPRESSION 2
95 MATERNAL EXPOSURE BEFORE PREGNANCY 2
96 MENISCUS INJURY 2
97 MIGRAINE 2
98 MUSCULAR WEAKNESS 2
99 MYALGIA 2
100 PRODUCT DISTRIBUTION ISSUE 2
101 PRODUCT PRESCRIBING ISSUE 2
102 PYREXIA 2
103 RASH PRURITIC 2
104 SEBORRHOEA 2
105 SEPSIS 2
106 SINUSITIS 2
107 SKIN ABRASION 2
108 SKIN DISORDER 2
109 SKIN HYPOPIGMENTATION 2
110 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2
111 THERAPEUTIC RESPONSE SHORTENED 2
112 THERAPY INTERRUPTED 2
113 THROAT IRRITATION 2
114 UPPER RESPIRATORY TRACT INFECTION 2
115 URTICARIA 2
116 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2
117 ACUTE CARDIAC EVENT 1
118 ACUTE SINUSITIS 1
119 ADENOMA BENIGN 1
120 AGEUSIA 1
121 AGGRESSION 1
122 AGITATION 1
123 ALANINE AMINOTRANSFERASE INCREASED 1
124 ALLERGIC COUGH 1
125 ALOPECIA 1
126 AMNIOTIC FLUID INDEX DECREASED 1
127 ANAL FISSURE 1
128 ANAPHYLACTIC SHOCK 1
129 ANGLE CLOSURE GLAUCOMA 1
130 ANOSMIA 1
131 ANXIETY 1
132 APPLICATION SITE ATROPHY 1
133 APPLICATION SITE BURN 1
134 APPLICATION SITE DISCOLOURATION 1
135 APPLICATION SITE HAEMORRHAGE 1
136 APPLICATION SITE INFLAMMATION 1
137 APPLICATION SITE LACERATION 1
138 APPLICATION SITE SCAB 1
139 APPLICATION SITE STREAKING 1
140 ARTHROPATHY 1
141 ASTHENIA 1
142 ATRIAL FIBRILLATION 1
143 BACK DISORDER 1
144 BACK PAIN 1
145 BLISTER 1
146 BLISTER INFECTED 1
147 BLOOD GLUCOSE FLUCTUATION 1
148 BLOOD GLUCOSE INCREASED 1
149 BLOOD IMMUNOGLOBULIN A DECREASED 1
150 BLOOD IRON DECREASED 1
151 BLOOD TESTOSTERONE DECREASED 1
152 BODY HEIGHT DECREASED 1
153 BONE LOSS 1
154 BOWEL MOVEMENT IRREGULARITY 1
155 BRAIN OPERATION 1
156 BREAST CANCER 1
157 BREAST CANCER FEMALE 1
158 BREAST SWELLING 1
159 CANDIDA INFECTION 1
160 CATARACT 1
161 CELLULITIS STAPHYLOCOCCAL 1
162 CENTRAL SEROUS CHORIORETINOPATHY 1
163 CHEMICAL BURN 1
164 CHEMICAL BURN OF SKIN 1
165 CHRONIC SPONTANEOUS URTICARIA 1
166 COLD SWEAT 1
167 COLD URTICARIA 1
168 CONTRAINDICATION TO MEDICAL TREATMENT 1
169 CORNEAL ENDOTHELIITIS 1
170 COVID-19 IMMUNISATION 1
171 CRYING 1
172 CYST 1
173 CYST RUPTURE 1
174 DANDRUFF 1
175 DEHYDRATION 1
176 DEPRESSED MOOD 1
177 DERMATITIS ALLERGIC 1
178 DEVICE LEAKAGE 1
179 DIABETIC FOOT 1
180 DISTURBANCE IN ATTENTION 1
181 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1
182 DRUG INTOLERANCE 1
183 DRUG TOLERANCE 1
184 DYSPEPSIA 1
185 DYSPHONIA 1
186 DYSPLASIA 1
187 DYSPNOEA 1
188 EMOTIONAL DISORDER 1
189 ENDOVENOUS ABLATION 1
190 EOSINOPHILIC CELLULITIS 1
191 ERECTILE DYSFUNCTION 1
192 EYE DISCHARGE 1
193 EYE INFECTION 1
194 EYE IRRITATION 1
195 EYE SWELLING 1
196 FACIAL PAIN 1
197 FALL 1
198 FAMILY STRESS 1
199 FEELING HOT 1
200 FEELING JITTERY 1
201 FOETAL HYPOKINESIA 1
202 GASTRIC PERFORATION 1
203 GASTROENTERITIS VIRAL 1
204 GASTROINTESTINAL DISORDER 1
205 GOUT 1
206 GOUTY ARTHRITIS 1
207 HAEMORRHOIDS 1
208 HERPES ZOSTER 1
209 HORDEOLUM 1
210 HOSPITALISATION 1
211 HYPERHIDROSIS 1
212 HYPERKERATOSIS 1
213 HYPERTENSION 1
214 ILL-DEFINED DISORDER 1
215 IMPLANT SITE INFECTION 1
216 INCORRECT DOSE ADMINISTERED 1
217 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1
218 INCREASED APPETITE 1
219 INFECTION 1
220 INFLUENZA LIKE ILLNESS 1
221 INJECTION SITE BRUISING 1
222 INJECTION SITE MASS 1
223 INJECTION SITE PAPULE 1
224 INTENTIONAL DOSE OMISSION 1
225 INTERCEPTED PRODUCT PREPARATION ERROR 1
226 INTRAUTERINE CONTRACEPTION 1
227 IRRITABILITY 1
228 IRRITABLE BOWEL SYNDROME 1
229 JOINT INJURY 1
230 LIVER FUNCTION TEST INCREASED 1
231 LOSS OF CONSCIOUSNESS 1
232 LOWER LIMB FRACTURE 1
233 LOWER RESPIRATORY TRACT INFECTION 1
234 LYMPHOEDEMA 1
235 MELANOCYTIC NAEVUS 1
236 METABOLIC DYSFUNCTION-ASSOCIATED LIVER DISEASE 1
237 MOVEMENT DISORDER 1
238 MUSCLE SPASMS 1
239 MUSCULOSKELETAL CHEST PAIN 1
240 MYOCARDIAL INFARCTION 1
241 NAIL GROWTH ABNORMAL 1
242 NASAL CONGESTION 1
243 NASOPHARYNGITIS 1
244 NECK PAIN 1
245 NEEDLE ISSUE 1
246 NEOPLASM MALIGNANT 1
247 NERVOUSNESS 1
248 NEURODERMATITIS 1
249 NORMAL NEWBORN 1
250 OROPHARYNGEAL PAIN 1
251 PAIN IN EXTREMITY 1
252 PAIN IN JAW 1
253 PALPITATIONS 1
254 PARONYCHIA 1
255 PATIENT DISSATISFACTION WITH TREATMENT 1
256 PERIORAL DERMATITIS 1
257 PIGMENTATION DISORDER 1
258 POLYMYALGIA RHEUMATICA 1
259 POOR QUALITY SLEEP 1
260 PROCEDURAL PAIN 1
261 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1
262 PRODUCT ADMINISTRATION INTERRUPTED 1
263 PRODUCT AVAILABILITY ISSUE 1
264 PRODUCT DOSE OMISSION 1
265 PRODUCT PHYSICAL CONSISTENCY ISSUE 1
266 PRODUCT QUALITY ISSUE 1
267 PRODUCT TEMPERATURE EXCURSION ISSUE 1
268 PRODUCT USE COMPLAINT 1
269 PRODUCTIVE COUGH 1
270 PURPURA 1
271 RASH MACULAR 1
272 REBOUND EFFECT 1
273 RHEUMATOID ARTHRITIS 1
274 RHINORRHOEA 1
275 ROAD TRAFFIC ACCIDENT 1
276 ROSACEA 1
277 SCRATCH 1
278 SENSATION OF FOREIGN BODY 1
279 SENSITIVE SKIN 1
280 SHOULDER OPERATION 1
281 SKIN CANCER 1
282 SKIN DEPIGMENTATION 1
283 SKIN FISSURES 1
284 SKIN HAEMORRHAGE 1
285 SKIN LESION 1
286 SKIN TIGHTNESS 1
287 SKIN ULCER 1
288 SNEEZING 1
289 SOMNOLENCE 1
290 SQUAMOUS CELL CARCINOMA OF SKIN 1
291 STAPHYLOCOCCAL INFECTION 1
292 SUBCUTANEOUS ABSCESS 1
293 SURGERY 1
294 SYMPTOM RECURRENCE 1
295 THERAPY CESSATION 1
296 THERMAL BURN 1
297 THREAT OF REDUNDANCY 1
298 TINNITUS 1
299 TOOTH EXTRACTION 1
300 TOOTH INFECTION 1
301 ULCER 1
302 UNEVALUABLE EVENT 1
303 UPPER LIMB FRACTURE 1
304 URINARY TRACT INFECTION 1
305 UTERINE PROLAPSE 1
306 VISION BLURRED 1
307 VULVAL CANCER 1
308 WEIGHT DECREASED 1
309 WEIGHT INCREASED 1
310 WHITE BLOOD CELL COUNT INCREASED 1
311 WOUND 1